Langerhans cell histiocytosis in children under 12 months of age: The spectrum of imaging and clinical findings: Experience in an Irish tertiary referral centre

被引:1
|
作者
Gargan, Mary-Louise [1 ,2 ]
Wong, Jsun Loong [1 ,2 ]
Leidhin, Caoilfhionn Ni [1 ,2 ]
Owens, Cormac [1 ,2 ]
Byrne, Angela [1 ,2 ]
机构
[1] Childrens Hlth Ireland Crumlin, Dublin, Ireland
[2] Childrens Hlth Ireland, Cooley Rd, Dublin D12 N512, Ireland
关键词
Paediatric; Oncology; LCH; Radiology; Neonates; Multisystem; Clinical; INVOLVEMENT; DISEASE;
D O I
10.1016/j.ejrad.2020.109375
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: Langerhans cell histiocytosis is an uncommon condition and it is unusual for it to present in children under one year of age. Our aim is to review the clinical presentation, and present the radiologic findings and clinical outcome in this particular cohort of patients and determine how this differs from the imaging features of older children presenting with LCH. Materials and methods: A database of 17 patients with LCH who presented between 0 and 12 months of age was retrospectively reviewed. Radiologic findings, initial clinical presentation and ultimate clinical outcome were documented in table format. Results: Eight patients (47 %) initially presented with cutaneous stigmata, seven patients (41 %) had skeletal involvement, five patients (29 %) had splenic involvement, two patients (24 %) had central nervous system involvement either at presentation or at follow-up, three patients (18 %) had lymphadenopathy, two patients (12 %) had liver involvement, and two patients (12 %) had gastrointestinal (GI) involvement. Four patients (24 %) had multisystem involvement either at presentation or at follow-up. One patient died during follow-up. Conclusion: LCH in children under one year of age is uncommon and may have an unusual clinical presentation. The radiologic findings are varied and may differ from the classical imaging appearance more commonly seen in the older age group, with multisystem involvement seen more readily in younger patients.
引用
收藏
页数:9
相关论文
共 43 条
  • [41] Demographics, treatment patterns and clinical outcomes in ROS1-positive non-small cell lung cancer: A referral tertiary cancer centre experience from a low-middle income country
    Panda, G. S.
    Noronha, V.
    Patil, V. M.
    Joshi, A. P.
    Menon, N. S.
    Singh, A. C.
    Kumar, R.
    Pai, T.
    Shetty, O.
    Janu, A.
    Chakrabarty, N.
    Purandare, N.
    Dey, S.
    Prabhash, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1594 - S1595
  • [42] Clinical outcomes of ROS1-positive non-small cell lung cancer with limited access to ROS1-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centre
    Panda, Goutam Santosh
    Noronha, Vanita
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Kumar, Rajiv
    Pai, Trupti
    Shetty, Omshree
    Janu, Amit
    Chakrabarty, Nivedita
    Purandare, Nilendu
    Dey, Sayak
    Prabhash, Kumar
    ECANCERMEDICALSCIENCE, 2024, 18
  • [43] Desmoplastic Small Round Cell Tumor-Clinicopathological Spectrum, Including Unusual Features and Immunohistochemical Analysis of 45 Tumors Diagnosed at a Tertiary Cancer Referral Centre, with Molecular Results t(11;22) (p13; q12) (EWS-WT1) in Select Cases
    Rekhi, Bharat
    Ahmed, Sharique
    Basak, Ranjan
    Qureshi, Sajid S.
    Desai, Saral S.
    Ramadwar, Mukta
    Desai, Sangeeta B.
    Kurkure, Purna
    Jambhekar, Nirmala A.
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (04) : 917 - 927